Cross MA - Search Results

1

Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants.

Wynn RF, Cross MA, Hatton C, Will AM, Lashford LS, Dexter TM, Testa NG. Wynn RF, et al. Among authors: cross ma. Lancet. 1998 Jan 17;351(9097):178-81. doi: 10.1016/S0140-6736(97)08256-1. Lancet. 1998. PMID: 9449873

2

Telomeres and haemopoiesis.

Wynn RF, Cross MA, Testa NG. Wynn RF, et al. Among authors: cross ma. Br J Haematol. 1998 Dec;103(3):591-3. doi: 10.1046/j.1365-2141.1998.01092.x. Br J Haematol. 1998. PMID: 9858205 Free article. No abstract available.

3

Expression of lineage restricted transcription factors precedes lineage specific differentiation in a multipotent haemopoietic progenitor cell line.

Cross MA, Heyworth CM, Murrell AM, Bockamp EO, Dexter TM, Green AR. Cross MA, et al. Oncogene. 1994 Oct;9(10):3013-6. Oncogene. 1994. PMID: 8084606

4

How do stem cells decide what to do?

Cross MA, Heyworth CM, Dexter TM. Cross MA, et al. Ciba Found Symp. 1997;204:3-14; discussion 14-8. doi: 10.1002/9780470515280.ch2. Ciba Found Symp. 1997. PMID: 9107406 Review.

5

Differential response of CD34+ cells isolated from cord blood and bone marrow to MIP-1 alpha and the expression of MIP-1 alpha receptors on these immature cells.

de Wynter EA, Durig J, Cross MA, Heyworth CM, Testa NG. de Wynter EA, et al. Among authors: cross ma. Stem Cells. 1998;16(5):349-56. doi: 10.1002/stem.160349. Stem Cells. 1998. PMID: 9766815

6

Expression of macrophage inflammatory protein-1 receptors in human CD34(+) hematopoietic cells and their modulation by tumor necrosis factor-alpha and interferon-gamma.

Dürig J, de Wynter EA, Kasper C, Cross MA, Chang J, Testa NG, Heyworth CM. Dürig J, et al. Among authors: cross ma. Blood. 1998 Nov 1;92(9):3073-81. Blood. 1998. PMID: 9787141 Free article.

7

Growth factors in development, transformation, and tumorigenesis.

Cross M, Dexter TM. Cross M, et al. Cell. 1991 Jan 25;64(2):271-80. doi: 10.1016/0092-8674(91)90638-f. Cell. 1991. PMID: 1988148 Review.

8

A reliable approach for sequencing clone-specific CDRIII regions in B-cell lymphoma.

Straka C, Pettengell R, Pielmeier A, Cross M, Emmerich B, Crowther D, Testa NG, Dexter TM. Straka C, et al. Ann Oncol. 1994;5 Suppl 1:79-84. doi: 10.1093/annonc/5.suppl_1.s79. Ann Oncol. 1994. PMID: 8172824 Clinical Trial.

9

Identification of a serpin specifically expressed in multipotent and bipotent hematopoietic progenitor cells and in activated T cells.

Hampson IN, Hampson L, Pinkoski M, Cross M, Heyworth CM, Bleackley RC, Atkinson E, Dexter TM. Hampson IN, et al. Blood. 1997 Jan 1;89(1):108-18. Blood. 1997. PMID: 8978283 Free article.

10

Erythroid development of the FDCP-Mix A4 multipotent cell line is governed by the relative concentrations of erythropoietin and interleukin 3.

Heyworth CM, Alauldin M, Cross MA, Fairbairn LJ, Dexter TM, Whetton AD. Heyworth CM, et al. Among authors: cross ma. Br J Haematol. 1995 Sep;91(1):15-22. doi: 10.1111/j.1365-2141.1995.tb05238.x. Br J Haematol. 1995. PMID: 7577622

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters